|
Meno:
|
doc. MUDr. Ivan Solovič, CSc. | |
|
Email:
|
ivan.solovic@ku.sk | |
|
Homepage:
|
http:// | |
|
Fakulta/Univerzita:
|
FZ KU
-
Fakulta zdravotníctva Katolíckej univerzity v Ružomberku
|
|
|
Pracovisko:
|
KLVM
-
Katedra laboratórnych vyšetrovacích metód
|
| II.a - Názov vysokej školy alebo inštitúcie | II.b - Rok | II.c - Odbor a program |
|---|---|---|
| Lekárska fakulta Univerzity Komenského Bratislava | 1991 | všeobecné lekárstvo |
| II.a - Názov vysokej školy alebo inštitúcie | II.b - Rok | II.c - Odbor a program |
|---|---|---|
| Lekárska fakulta Univerzity Komenského Bratislava | 1991 | všeobecné lekárstvo |
| II.a - Názov vysokej školy alebo inštitúcie | II.b - Rok | II.c - Odbor a program |
|---|---|---|
| Lekárska fakulta Univerzity Komenského Bratislava | 1997 | Náuka o zdravotníctve |
| III.a - Zamestnanie-pracovné zaradenie | III.b - Inštitúcia | III.c - Časové vymedzenie |
|---|---|---|
| univerzitný profesor | Fakulta zdravotníctva KU Ružomberok | 2003- doteraz |
| docent | SZU Bratislava | 2025- doteraz |
| primár | NUTPCHaHCH Vyšné Hágy | 1991- doteraz |
| V.1.a - Názov profilového predmetu | V.1.b - Študijný program | V.1.c - Stupeň | V.1.d - Študijný odbor |
|---|---|---|---|
| Právo a legislatíva v zdravotníctve | LVM, RAT, Ošetrovateľstsvo | I. | zdravotnícke vedy |
| Biochémia | LVM | I. | zdravotnícke vedy |
| V.2.a - Názov študijného programu | V.2.b - Stupeň | V.2.c - Študijný odbor |
|---|---|---|
| Laboratórne vyšetrovacie metódy | I. | zdravotnícke vedy |
| V.5.a - Názov predmetu | V.5.b - Študijný program | V.5.c - Stupeň | V.5.d - Študijný odbor |
|---|---|---|---|
| Právo a legislatíva | LVM, RAT, Fyzioterapia | I.+II. | zdravotnícke vedy |
| Právo a legislatíva | Ošetrovateľstvo | I. | ošetrovateľstvo |
Solovič, I. Sester, J.J. Gomez-Reino, H.L. Rieder, S. Ehlers, H.J. Milburn, B. Kampmann, B. Hellmich, R. Groves, S. Schreiber, R.S. Wallis, G. Sotgiu, E.H. Schölvinck, D. Goletti, J.P. Zellweger, R. Diel, L. Carmona, F. Bartalesi, P. Ravn, A. Bossink, R. Duarte, C. Erkens, J. Clark, G.B. Migliori, and C. Lange SERIES “UPDATE ON TUBERCULOSIS” Edited by C. Lange, M. Raviglione, W.W. Yew and G.B. Migliori Number 2 in this Series: The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Eur Respir J 2010 36:1185-1206; published ahead of print 2010, doi:10.1183/09031936.00028510 ISSN 0903-1936, ONLINE ISSN 1399-3003
Masoud Dara, Ivan Solovic, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Delia Goletti, Raquel Duarte, Stefano Aliberti, Fernando Maria de Benedictis, Graham Bothamley, Tom Schaberg, Ibrahim Abubakar, Brian Ward, Vitor Teixeira, Christina Gratziou, Giovanni Battista Migliori: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease: call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees. ERJ Exppress Published on March 23, 2016 as DOI: 10.1183/13993003.00377-2016 Published 23 March 2016
Ivan Solovic, Rosella Centis, Lia D'Ambrosio, Dina Visca, Giovanni Battista Migliori: World TB Day 2017: Strengthening the fight against TB.Presse Med. 2017, 46: n2, e1-e4 IF 1,015 Solovic I, Centis R, D'Ambrosio L, Visca D, Battista Migliori G. World TB Day Strengthening the fight against TB. Presse Med. 2017 Mar;46(2 Pt 2):e1-e4. doi: 10.1016/j.lpm.2017.02.002. PubMed PMID: 28336002.
Solovic I, Abubakar I, Sotgiu G, Dara M, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Ward B, Teixeira V, Gratziou C, Migliori GB. Standard operating procedures for tuberculosis care. Eur Respir J. 2017 Jun 1;49(6). pii: 1700515. doi: 10.1183/13993003.00515-2017. Print 2017 Jun. PubMed PMID: 28572129.
Ivan Solovic, Rosella Centis, Lia D'Ambrosio, Dina Visca, Giovanni Battista Migliori: World TB Day 2017: Strengthening the fight against TB.Presse Med. 2017, 46: n2, e1-e4 IF 1,015 Solovic I, Centis R, D'Ambrosio L, Visca D, Battista Migliori G. World TB Day Strengthening the fight against TB. Presse Med. 2017 Mar;46(2 Pt 2):e1-e4. doi: 10.1016/j.lpm.2017.02.002. PubMed PMID: 28336002.
Dohál M., Wetzstein N., Hromádková M., Mäsiarová S., Rasmussen E.M., Kunč P., Škereňová M., Porvazník I., Solovič I., Niemann S., Hnilicová J., Mokrý J., Dvořáková V., Diricks M.
Diagnostics, resistance and clinical relevance of non-tuberculous mycobacteria unidentified at the species level by line probe assays: a bi-national study
(2025) Annals of Clinical Microbiology and Antimicrobials, 24 (1), art. no. 14
Saminathan G., Kumar V., Shanmugam S., Rajendran P.
Revolutionizing non-tuberculous mycobacteria research: Advances in molecular diagnostics, phylogenetics, and clinical management
(2025) Journal of Microbiological Methods, 237, art. no. 107226
Wang X., Zhao L., Zhao H., Wang M.-S., Li Z., He Y.
Diagnostic performance of MALDI-TOF MS for non-tuberculous mycobacteria: A systematic review and meta-analysis
(2025) European Journal of Clinical Microbiology and Infectious Diseases
Krivošová M., Dohál M., Mäsiarová S., Pršo K., Gondáš E., Murín R., Fraňová S., Porvazník I., Solovič I., Mokrý J.
Exploring cytokine dynamics in tuberculosis: A comparative analysis of patients and controls with insights from three-week antituberculosis intervention
(2024) PLoS ONE, 19 (8 August), art. no. e0305158
Wang Z., Bo H., Cheng C., Gan T., Peng J., Zou Y., Jiang H., Wang H.
Analysis of the efficacy of Langhans giant cells in controlling cutaneous Mycobacterium marinum infections
(2025) International Immunopharmacology, 148, art. no. 114003
Diallo D., Sun S., Somboro A.M., Baya B., Koné A., Diarra B., Nantoumé M., Koloma I., Diakite M., Holl J., Maiga A.I., Seydi M., Theron G., Hou L., Fodor A., Maiga M.
Metabolic and immune consequences of antibiotic related microbiome alterations during first-line tuberculosis treatment in Bamako, Mali
(2025) Frontiers in Immunology, 16, art. no. 1561459
Vyšehradský P., Solovič I., Kotúľová L., Grendár M., Rákošová M., Hudečková H., Vyšehradský R.
Social differences between the general population and tuberculosis patients in Slovakia
(2025) Frontiers in Public Health, 13, art. no. 1541882
Scholze A.R., Bersi P.O., Silva M.C.D., Martins J.T., Melo E.C., Galdino M.J.Q., Pieri F.M., Delpino F.M., Alves Y.M., Berra T.Z., Munhoz O.L., Alves J.D., Yamamura M., Arcêncio R.A.
Prevalence and Factors Associated with Tuberculosis Among Healthcare Workers: A Systematic Review with Meta-Analysis
(2025) Microbiology Research, 16 (8), art. no. 191
Rodriguez A., Purvinsh Y., Zhang J., Rogovskyy A.S., Kurouski D.
Nano-Infrared Detection and Identification of Bacteria at the Single-Cell Level
(2025) Analytical Chemistry, 97 (17), pp. 9535 – 9539
Dohál M., Wetzstein N., Hromádková M., Mäsiarová S., Rasmussen E.M., Kunč P., Škereňová M., Porvazník I., Solovič I., Niemann S., Hnilicová J., Mokrý J., Dvořáková V., Diricks M.
Diagnostics, resistance and clinical relevance of non-tuberculous mycobacteria unidentified at the species level by line probe assays: a bi-national study
(2025) Annals of Clinical Microbiology and Antimicrobials, 24 (1), art. no. 14
Saminathan G., Kumar V., Shanmugam S., Rajendran P.
Revolutionizing non-tuberculous mycobacteria research: Advances in molecular diagnostics, phylogenetics, and clinical management
(2025) Journal of Microbiological Methods, 237, art. no. 107226
Wang X., Zhao L., Zhao H., Wang M.-S., Li Z., He Y.
Diagnostic performance of MALDI-TOF MS for non-tuberculous mycobacteria: A systematic review and meta-analysis
(2025) European Journal of Clinical Microbiology and Infectious Diseases
Nasiri M.J., Silva D.R., Rommasi F., Zahmatkesh M.M., Tajabadi Z., Khelghati F., Sarmastzadeh T., Centis R., D'Ambrosio L., Bombarda S., Dalcolmo M.P., Galvão T., de Queiroz Mello F.C., Rabahi M.F., Pontali E., Solovic I., Tadolini M., Marconi L., Tiberi S., van den Boom M., Sotgiu G., Migliori G.B.
Vaccination in post-tuberculosis lung disease management: A review of the evidence
(2023) Pulmonology
Thu W.P.P., Hu T.H., D'Ambrosio L., Centis R., Ong C.W.M., Migliori G.B.
Charting the Course in Post-Tuberculosis Lung Disease: From Inflammation to Intervention
(2025) Archivos de Bronconeumologia, 61 (12), pp. 757 – 765
Wang J., Yuan B., Fang Y., Zhao C., Liu J., Xiong K.
Post-tuberculosis morbidities and their associated mortality: moving from challenges to solutions
(2025) European Respiratory Review, 34 (178), art. no. 250148
Beyond a cure for TB: confronting the hidden burden of post-TB lung disease
(2025) IJTLD Open, 2 (5), pp. 248 – 250
Silva D.R., Pontali E., Kherabi Y., D'Ambrosio L., Centis R., Migliori G.B.
Post-TB Lung Disease: Where are we to Respond to This Priority?
(2025) Archivos de Bronconeumologia, 61 (5), pp. 262 – 263
Migliori G.B., Centis R., D’Ambrosio L., Silva D.R., Podlekareva D., Schaaf H.S.
Post-tuberculosis lung disease: questions and answers
(2025) European Respiratory Journal, 66 (2), art. no. 2500992
Fumagalli G., Mencarini J., Sini I., Allavena L., Tadolini M., Mantero M., Blasi F., Riccardi N., Pontarelli A., Piccioni P., Calcagno A., Sotgiu G., Shah D., Codecasa L.R., Parrella R., StopTB Italia ODV
Post-tuberculosis lung disease: a guide for clinicians
(2025) Infection
Dohál M., Wetzstein N., Hromádková M., Mäsiarová S., Rasmussen E.M., Kunč P., Škereňová M., Porvazník I., Solovič I., Niemann S., Hnilicová J., Mokrý J., Dvořáková V., Diricks M.
Diagnostics, resistance and clinical relevance of non-tuberculous mycobacteria unidentified at the species level by line probe assays: a bi-national study
(2025) Annals of Clinical Microbiology and Antimicrobials, 24 (1), art. no. 14
Saminathan G., Kumar V., Shanmugam S., Rajendran P.
Revolutionizing non-tuberculous mycobacteria research: Advances in molecular diagnostics, phylogenetics, and clinical management
(2025) Journal of Microbiological Methods, 237, art. no. 107226
Wang X., Zhao L., Zhao H., Wang M.-S., Li Z., He Y.
Diagnostic performance of MALDI-TOF MS for non-tuberculous mycobacteria: A systematic review and meta-analysis
(2025) European Journal of Clinical Microbiology and Infectious Diseases
Dohál M., Dvořáková V., Šperková M., Pinková M., Ghodousi A., Omrani M., Porvazník I., Rasmussen E.M., Škereňová M., Krivošová M., Wallenfels J., Konstantynovska O., Walker T.M., Nikolayevskyy V., Cirillo D.M., Solovič I., Mokrý J.
Tuberculosis in Ukrainian War Refugees and Migrants in the Czech Republic and Slovakia: A Molecular Epidemiological Study
(2024) Journal of Epidemiology and Global Health, 14 (1), pp. 35 – 44
Jackson S., Hauer B., Guthmann J.-P., O´Meara M., Sizaire V., Nordstrand K., Koch A., Häcker B., de Vries G., Jonsson J., Kristensen K.L., de Oñate W.A., Soini H., Domaszewska T.
Differences found in patient characteristics of migrant tuberculosis sub-populations within low TB incidence European countries, 2014–2020
(2025) BMC Infectious Diseases, 25 (1), art. no. 787
Caliman-Sturdza O.A., Gheorghita R., Terteliu Baitan M., Filip R.
Infectious Diseases in the Context of the War in Ukraine: Refugee Health Implications in Romania
(2025) Healthcare (Switzerland), 13 (21), art. no. 2732
Kashnitsky D., Vyatchina M., Rivera K., Desgrées du Loû A., Simmat-Durand L.
(Re)producing HIV Care for Ukrainian Refugees in Germany and Poland: Trans-Local Community-Based Support in Action
(2025) Social Sciences, 14 (10), art. no. 580
Parczewski M., Boesecke C., Khaykin P., Jilich D., Pǎtraşcu R., Kowalska J., Climasevschi I., Noori T.
Provision of care for people with HIV migrating from Ukraine: Preparing for a long-term response
(2025) AIDS, 39 (6), pp. 629 – 638
Centis R., D'Ambrosio L., Kurhasani X., Solovic I., Migliori G.B.
Tuberculosis Elimination: Myth or Achievable Target?
(2023) Archivos de Bronconeumologia, 59 (11), pp. 714 – 716
Silva D.R., Mello F.C.D.Q., Centis R., D'Ambrosio L., Raviglione M.C., Battista Migliori G.
Whither Tuberculosis: Is the Elimination Goal Realistic After the Double Shock?
(2025) Archivos de Bronconeumologia, 61 (9), pp. 519 – 521
Rodrigo T., Millet J.P., Bravo M., Tabernero E.M., Caylà J.A., Vázquez Rincón I., Durán Pla E., Montaño Remacha M.C., Fernández Ibáñez A., Giménez Durán J., Pérez Jiménez P., Pequeño S., López M., Gavaldà L., Cruz Ferro E., Rodríguez Baena M.E., Guirado Esteban I., Castilla Catalán J., Castrillejo Pérez D.
Evolution of tuberculosis in Spain: Will the objectives of the End TB Strategy be achieved in Western European countries? [Evolución de la tuberculosis en España: ¿se lograrán los objetivos de la Estrategia fin de la TB en los países de Europa occidental?]
(2025) Enfermedades Infecciosas y Microbiologia Clinica, 43 (7), pp. 426 – 434
Godoy S., Alsedà M., Parrón I., Millet J.-P., Caylà J.A., Follia N., Carol M., Orcau A., Toledo D., Ferrús G., Plans P., Barrabeig I., Clotet L., Domínguez A., March-Llanes J., Godoy P.
Exposure Time to a Tuberculosis Index Case as a Marker of Infection in Immigrant Populations
(2025) Pathogens, 14 (2), art. no. 175
Vasiliu A., Köhler N., Altpeter E., Ægisdóttir T.R., Amerali M., de Oñate W.A., Bakos Á., D’Amato S., Cirillo D.M., van Crevel R., Davidaviciene E., Demuth I., Domínguez J., Duarte R., Günther G., Guthmann J.-P., Hatzianastasiou S., Holm L.H., Herrador Z., Hribar U., Huberty C., Ibraim E., Jackson S., Jensenius M., Josefsdottir K.S., Koch A., Korzeniewska-Kosela M., Kuksa L., Kunst H., Lienhardt C., Mahler B., Makek M.J., Muylle I., Normark J., Pace-Asciak A., Petrović G., Pieridou D., Russo G., Rzhepishevska O., Salzer H.J.F., Marques M.S., Schmid D., Solovic I., Sukholytka M., Svetina P., Tyufekchieva M., Vasankari T., Viiklepp P., Villand K., Wallenfels J., Wesolowski S., Mandalakas A.-M., Martinez L., Zenner D., Lange C.
Tuberculosis incidence in foreign-born people residing in European countries in 2020
(2023) Eurosurveillance, 28 (42), art. no. 2300051
Jackson S., Kabir Z., Comiskey C.
Differences found in patient profiles and incidence trends between migrants and native-born tuberculosis patients in Ireland: A cross-sectional analysis of national surveillance data, 2011-2021
(2025) IJID Regions, 17, art. no. 100763
Jackson S., Hauer B., Guthmann J.-P., O´Meara M., Sizaire V., Nordstrand K., Koch A., Häcker B., de Vries G., Jonsson J., Kristensen K.L., de Oñate W.A., Soini H., Domaszewska T.
Differences found in patient characteristics of migrant tuberculosis sub-populations within low TB incidence European countries, 2014–2020
(2025) BMC Infectious Diseases, 25 (1), art. no. 787
Ennis C., Thilliez G., O’Toole R.F.
Geogenomic mapping of drug-resistant Mycobacterium tuberculosis from Ireland and overseas
(2025) Genomics, 117 (6), art. no. 111132
Nosan G., Cerkvenik Škafar A.
Screen first, vaccinate later: Enhancing tuberculosis vaccination safety through newborn immunodeficiency screening
(2025) Vaccine, 64, art. no. 127679
Fumagalli G., Riccardi N., Sbarbati M.M., Torri S., Leonardi G., Martearena M.D.C.G., Ferrarese M., Repossi A.C., de Giorgi S., Sotgiu G., Codecasa L.R.
Risk factors and treatment outcomes of drug-resistant TB in migrants: a retrospective study
(2025) International Journal of Tuberculosis and Lung Disease, 29 (10), pp. 473 – 475
Mahieu L., Barka A., Arrazola de Oñate W., Matheeussen V., Driessche K.V.
Congenital tuberculosis in a preterm neonate linked to female genital tuberculosis in a migrant mother: A case report
(2025) Travel Medicine and Infectious Disease, 66, art. no. 102859
Feuchtenberger M., Kovacs M.S., Nigg A., Schäfer A.
Detection of substantial numbers of latent tuberculosis and positive hepatitis B serology results in rheumatology patients preparing to receive intensified immunosuppressive therapy in a low-prevalence country: why screening still matters
(2025) Clinical Rheumatology, 44 (4), pp. 1851 – 1859
Domaszewska T., Koch A., Jackson S., Häcker B., Jonsson J., Kristensen K.L., Soini H., de Oñate W.A., Guthmann J.-P., Hauer B., O'Meara M., Nordstrand K., Sizaire V., de Vries G.
Tuberculosis rates in migrants in low-incidence European countries, according to country of origin, reporting country and recency of immigration, 2014 to 2020
(2025) Eurosurveillance, 30 (11), art. no. 2400489
Pinheiro M., Valente C., Cruz M., Nascimento Moreira D., Aguiar A., Duarte R.
European guidelines for the management of tuberculosis screening procedures in migrants: A systematic review
(2025) Pulmonology, 31 (1), art. no. 2482855
Kunst H., Lange B., Hovardovska O., Bockey A., Zenner D., Andersen A.B., Hargreaves S., Pareek M., Friedland J.S., Wejse C., Bothamley G., Guglielmetti L., Chesov D., Tiberi S., Matteelli A., Mandalakas A.M., Heyckendorf J., Eimer J., Malhotra A., Zamora J., Vasiliu A., Lange C.
Tuberculosis in adult migrants in Europe: a TBnet consensus statement
(2025) European Respiratory Journal, 65 (3), art. no. 2401612
Vasiliu A., Köhler N., Altpeter E., Ægisdóttir T.R., Amerali M., de Oñate W.A., Bakos Á., D’Amato S., Cirillo D.M., van Crevel R., Davidaviciene E., Demuth I., Domínguez J., Duarte R., Günther G., Guthmann J.-P., Hatzianastasiou S., Holm L.H., Herrador Z., Hribar U., Huberty C., Ibraim E., Jackson S., Jensenius M., Josefsdottir K.S., Koch A., Korzeniewska-Kosela M., Kuksa L., Kunst H., Lienhardt C., Mahler B., Makek M.J., Muylle I., Normark J., Pace-Asciak A., Petrović G., Pieridou D., Russo G., Rzhepishevska O., Salzer H.J.F., Marques M.S., Schmid D., Solovic I., Sukholytka M., Svetina P., Tyufekchieva M., Vasankari T., Viiklepp P., Villand K., Wallenfels J., Wesolowski S., Mandalakas A.-M., Martinez L., Zenner D., Lange C.
Tuberculosis incidence in foreign-born people residing in European countries in 2020
(2023) Eurosurveillance, 28 (42), art. no. 2300051
Jackson S., Kabir Z., Comiskey C.
Differences found in patient profiles and incidence trends between migrants and native-born tuberculosis patients in Ireland: A cross-sectional analysis of national surveillance data, 2011-2021
(2025) IJID Regions, 17, art. no. 100763
Jackson S., Hauer B., Guthmann J.-P., O´Meara M., Sizaire V., Nordstrand K., Koch A., Häcker B., de Vries G., Jonsson J., Kristensen K.L., de Oñate W.A., Soini H., Domaszewska T.
Differences found in patient characteristics of migrant tuberculosis sub-populations within low TB incidence European countries, 2014–2020
(2025) BMC Infectious Diseases, 25 (1), art. no. 787
Ennis C., Thilliez G., O’Toole R.F.
Geogenomic mapping of drug-resistant Mycobacterium tuberculosis from Ireland and overseas
(2025) Genomics, 117 (6), art. no. 111132
Nosan G., Cerkvenik Škafar A.
Screen first, vaccinate later: Enhancing tuberculosis vaccination safety through newborn immunodeficiency screening
(2025) Vaccine, 64, art. no. 127679
Fumagalli G., Riccardi N., Sbarbati M.M., Torri S., Leonardi G., Martearena M.D.C.G., Ferrarese M., Repossi A.C., de Giorgi S., Sotgiu G., Codecasa L.R.
Risk factors and treatment outcomes of drug-resistant TB in migrants: a retrospective study
(2025) International Journal of Tuberculosis and Lung Disease, 29 (10), pp. 473 – 475
Mahieu L., Barka A., Arrazola de Oñate W., Matheeussen V., Driessche K.V.
Congenital tuberculosis in a preterm neonate linked to female genital tuberculosis in a migrant mother: A case report
(2025) Travel Medicine and Infectious Disease, 66, art. no. 102859
Feuchtenberger M., Kovacs M.S., Nigg A., Schäfer A.
Detection of substantial numbers of latent tuberculosis and positive hepatitis B serology results in rheumatology patients preparing to receive intensified immunosuppressive therapy in a low-prevalence country: why screening still matters
(2025) Clinical Rheumatology, 44 (4), pp. 1851 – 1859
Domaszewska T., Koch A., Jackson S., Häcker B., Jonsson J., Kristensen K.L., Soini H., de Oñate W.A., Guthmann J.-P., Hauer B., O'Meara M., Nordstrand K., Sizaire V., de Vries G.
Tuberculosis rates in migrants in low-incidence European countries, according to country of origin, reporting country and recency of immigration, 2014 to 2020
(2025) Eurosurveillance, 30 (11), art. no. 2400489
Pinheiro M., Valente C., Cruz M., Nascimento Moreira D., Aguiar A., Duarte R.
European guidelines for the management of tuberculosis screening procedures in migrants: A systematic review
(2025) Pulmonology, 31 (1), art. no. 2482855
Kunst H., Lange B., Hovardovska O., Bockey A., Zenner D., Andersen A.B., Hargreaves S., Pareek M., Friedland J.S., Wejse C., Bothamley G., Guglielmetti L., Chesov D., Tiberi S., Matteelli A., Mandalakas A.M., Heyckendorf J., Eimer J., Malhotra A., Zamora J., Vasiliu A., Lange C.
Tuberculosis in adult migrants in Europe: a TBnet consensus statement
(2025) European Respiratory Journal, 65 (3), art. no. 2401612
Collaborative Center in Vysne Hagy, Slovakia
Rok podania: 2017
Roky riešenia: 2018-2022
Výstup: workshop on TB 2019,2021, realizované, plánované na rok 2022
https://apps.who.int/whocc/Detail.aspx?nSW0tOFJRn5KA1LSppreGg==
vedúci projektu
The TB/COVID-19 Global study group TB and COVID-19 co-infection
Roky riešenia 2020-2021
Výstup: Casco, N. et all.: The TB/COVID-19 Global study group TB and COVID-19 co-infection: Rationale and aims of a global study (2021) International Journal of Tuberculosis and Lung Disease, 25 (1), pp. 78-80.
člen realizačného tímu
Prácca s marginálnymi skupinami obyvateľstva v boji s tuberkulozou
Rok podania:2024
Roky riešenia: 2025
Výstup: workshop on TB Surveillance realizované 12/2025
vedúci projektu
Národné referenčné centrum pre mykobakterie
od r. 2025 ako klinik Centra
Národný register tuberkulózy, národný zástupca pre WHO – TB
Názov projektu: Global Tuberculosis Control, surveillance, planning,
financing
Realizácia projektu : od r. 2002 doteraz
vedúci projektu
| VIII.a - Názov inštitúcie | VIII.b - Sídlo inštitúcie | VIII.c - Obdobie trvania pôsobenia/pobytu (uviesť dátum odkedy dokedy trval pobyt) | VIII.d - Mobilitná schéma, pracovný kontrakt, iné (popísať) |
|---|---|---|---|
| 16.1.-20.1.1999 Cornell Seminary in TB in Eastern Europe (Salzburg) 11.-23.10.1999 Second Regional Workshop on Tuberculosis Control (Varšava, WHO) 24.-30.4.2000 Strategic Planning, Project Development and Project Management (Belfast, Phare Project) 10.-12.4.2002 Meeting of the WHO Working Group on DOTS Plus for MDRTB, Tallinn 19.-26.1.2003 krátkodobý poradca WHO monitorovacia misia Nukus, Karakalpakstan, Uzbekistan 6.5.-11.5.2003 krátkodobý poradca WHO monitorovacia misia Estónsko 14.-18.6.2003 9th Wolfheze meeting on TB control in Europe Holadsko 2.7.-10.7.2003 III. European Training Course WHO for NTP Managers and TB Consultants, Sondalo, Italy 27.3.-3.4.2004 krátkodobý poradca pre urad WHO, misia DOTS implementácia, Minsk, Bielorusko 30.5.-2.6.2004 10th Wolfheze Meeting on TB Control in Europe, Holandsko 26.9.-28.9.2004 WHO NTP Managers Meeting, Sinaia, Rumunsko 17.10.-27.10.2004 4.th International Public Health Workshop , Taipei, Taiwan 30.1.-6.2.2005 krátkodobý poradca WHO, misia kontroly liečby TBC vo väzenskmom systéme v Bielorusku 21.2.-25.2.2005 WHO/GFATM Round 5 Preparatory Workshop, Geneva, Švajčiarsko 27.3.-2.4.2005 krátkodobý poradca WHO, misia GFATM Round 5, Minsk, Bielorusko 10.5.-19.5.2005 krátkodobý poradca WHO, misia GFATM Round 5, Kyjev, Ukrajina 28.5.-2.6.2005 11th Wolfheze Meeting on TB Control in Europe, Holandsko 30.10.-4.11.2005 krátkodobý poradca WHO, misia GDF for Ukraine, predelivery mission to Ukraine, Kyjev, Dnepropetrovsk 15.2.-25.2.200 konzultant PATH,WHO misia Ukrajina, National TB Programme evaluation, Žitomír, Kyjev 9.4.-15.4.2006 konzultant PATH misia Ukrajina, Charkov, Dnepropetrovsk, projekt implementácie DOTS stratégie v pilotných oblastiach 15.5.-18.5.2006 WHO/GFATM Round 6 Preparatory Workshop, Geneva, Švajčiarsko 18.6.-25.6.2006 krátkodobý poradca WHO, misia GFATM Round 6, Minsk, Bielorusko 15.7.-23.7.2006 krátkodobý poradca WHO, kontrolná misia GFATM Round 6, Minsk, Bielorusko 29.7.-11.8.2006 konzultant PATH misia Ukrajina, Sevastopol, Krym, Donetsk, projekt implementácie DOTS stratégie v pilotných oblastiach 24.9.-27.9.2006 Míting národných korešpodentov EuroTB/WHO, Vilnius, Litva 9.11.-10.11.2006 TB míting Borstel Nemecko 4.2. - 6.2.2007 WHO – World Lung Foundation – OSI workshop TB and social exclusion workshop for Eastern European countries, Salzburg, Rakúsko 25.-27.4.2007 ECDC Workshop on Infectious Diseases and Social Determinants, Stockholm, Švedsko 11.-19.6.2007 krátkodobý poradca WHO, kontrolná misia GFATM Round 7, Kyjev, Ukrajina 23.-29.9.2007 krátkodobý poradca WHO, kontrolná misia Implementácia DOTS strategie v pilotných oblastiach Dnepropetrovska a Charkova, Ukrajina 30.9.-6.10.2007 krátkodobý poradca WHO, misia GDF for Turkmenistan, 2 year delivery mission to Turkmenistan, Ašchabad 8.-9..4.2008 ECDC and Competent Bodies: Working together on Health Communication, Švedsko 22.-23.4.2008 ECDC/ WHO Europe Joint TB information system training Stockholm, Švedsko 4.5.-7.5.2008 krátkodobý poradca WHO, kontrolná misia GFATM Round 8 Kyjev, Ukrajina 28.5.-30.5.2008 Status Quo of Public Health Services in EU Countries, Berlín, Nemecko 16.6.-22.6.2008 krátkodobý poradca WHO, kontrolná misia GFATM Round 8 Kyjev, Ukrajina 30.6.-1.7.2009 Meeting on Tuberculosis, EC, ECDC, WHO, Luxembourg 31.5.- 3.6.2010 9th WHO National TB Programme Managers Meeting The Hague, Holandsko 4.10.-9.10.2010 krátkodobý poradca WHO Programm of the fight against TB in Doneck Oblast, Ukrajina 12.6-18.6.2011 krátkodobý poradca WHO Národný program boja proti TBC v Srbsku 20.-21.1.2014 WHO Executive Board 134th session, člen národnej delegácie, kosponzor rezolúcie Global strategy and targets for tuberculosis prevention, care and control after 2015 30.-31.3.2015 vedúci národnej delegácie Eastern Partnership Ministerial Conference on Tuberculosis and Its Multi –Drug Resistance, Riga, Lotyšsko a ERS Representative 12.-13.11.2015 Regional consultation on childhood tuberculosis in the WHO European Region, Copenhagen, Denmark 17.3.2016 Round table on TB –SK EU Pres. Brussel, Belgicko 10.-11.5.2016 Interregional workshop for TB control and care among refugees and migrant populations v Catanii Taliansko 14.-15.7.2016 Working party on Public Health at Senior level Brussel, Belgicko 3.-4.10.2016 Informal ministerial meeting of the EU Coucil Bratislava člen delegácie 7.-9.11.2016 Ad hoc scientific panel meeting for developing a guidance on programmatic latent tuberculosis infection control in the EU/EEA and candidate countries at the ECDC offices Stockholm Švedsko 29.5.-2.6.2017 15th WHO National TB Programme Managers Meeting The Hague, Holandsko 15.17.11.2017 1. Ministerial conference on TB Moskva Rusko, vedúci expert vládnej delegácie SR 28.-30.5.2018 ECDC Stockholm Švedsko porada TB Surveilllance a DNCC míting 24.-30.9.2018 člen delegácie prezidenta SR na Valnom zhromaždení OSN v New Yorku, aktívna účasť – vystúpenie na zhromaždení venovanom problematike tuberkulózy – príspevok za SR 13.-17.5.2019 16th WHO/ECDC National TB Programme Managers Meeting The Hague, Holandsko 10.-12.11.2019 WHO Euro porada zástupcov kolaboratívnych centier Kodaň, Dánsko 28.-31.1.2020 Regional consultation on childhood tuberculosis in the WHO European Region, Copenhagen, Denmark |
Práca pre WHO od roku 2002 expert WHO pre liečbu multirezistentnej TBC a implementáciu stratégie DOTS v liečbe TBC